DavidAPriceMDFACE

Endocrinology • San Francisco, CA

Diabetes

Retired VP Medical Affairs Dexcom

Join to view full profile

Dr. Price is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Price's full profile

Already have an account?

Office
None
San Francisco, CA 94115
Is this information wrong?

Education & Training

Joslin Diabetes CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1986
Maine Medical CenterResidency, Internal Medicine, 1982 - 1985
Ohio State University College of MedicineClass of 1982
Washington University in St. LouisBA, Biology, 1975 - 1978

Certifications & Licensure

CA State Medical License 1986 - 2024
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Continuous Monitoring and Control of Hypoglycemia Start of enrollment: 2017 Oct 20
Recruiting

Publications & Presentations

PubMed

2 citations
A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
Maamoun Salam, Ryan Bailey, Peter Calhoun, Janet B McGill, Richard M Bergenstal, David Price, Roy W Beck> ;Diabetes Technology & Therapeutics. 2023 Mar 1
1 citations
Feasibility of Using a Factory-Calibrated Continuous Glucose Monitoring System to Diagnose Type 2 Diabetes.
Spencer Frank, Kazanna C Hames, Abdulrahman Jbaily, Jee Hye Park, Chuck Stroyeck, David Price> ;Diabetes Technology & Therapeutics. 2022 Dec 1
7 citations
Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study.
Georgia Davis, Ryan Bailey, Peter Calhoun, David Price, Roy W Beck> ;Diabetes Technology & Therapeutics. 2022 May 1
9 citations
Non-adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): Results of a post-approval observational study.
Stayce E Beck, David Price> ;Diabetic Medicine. 2021 Nov 10
26 citations
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
, , , , , , , , , , , , , , , , , , , , , , > ;Diabetes Care. 2021 Sep 29
4 citations
Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes
Stephanie Edwards, Xuanyao He, Wenjie Wang, Jiat-Ling Poon, David Price, Jennal Johnson, Howard Wolpert, William H. Polonsky> ;Diabetes Technology & Therapeutics. 2021 Nov 1
2 citations
Continuous glucose monitoring in an end-stage renal disease patient with diabetes receiving hemodialysis.
Yoko Narasaki, Elisa Park, Amy S. You, Andrea Daza, Rene Amel Peralta, Yalitzi Guerrero, Alejandra Novoa, Alpesh Amin, Danh V. Nguyen, David Price, Kamyar Kalantar-Zad...> ;Seminars in Dialysis. 2021 Aug 10
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, McGill JB, Al...> ;JAMA.
Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial.
Price DA, Deng Q, Kipnes M, Beck SE> ;Diabetes therapy : research, treatment and education of diabetes and related disorders. 2021-06-04
10 citations
"Hyperglycemia aversiveness": Investigating an overlooked problem among adults with type 1 diabetes.
William H. Polonsky, Addie L. Fortmann, D. Price, Lawrence Fisher> ;Journal of Diabetes and Its Complications. 2021 Mar 29
8 citations
Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data.
Anne L. Peters, Nathan Cohen, Peter Calhoun, Katrina J. Ruedy, Roy W. Beck, Thomas W. Martens, Shichun Bao, Nelly Njeru, Stayce E Beck, David Price> ;Diabetes, Obesity & Metabolism. 2021 Feb 1
Earlier Detection of GDM Via OGTT: Is It Helpful?
Amy M. Valent, David Price> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Jan 23
5 citations
Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study.
Peter Calhoun, David Price, Roy W. Beck> ;Diabetes Technology & Therapeutics. 2021 Feb 25
6 citations
Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views:
Sarah Puhr, Mark Derdzinski, Andrew Scott Parker, John B. Welsh, David Price> ;Journal of Diabetes Science and Technology. 2020 Jan 1
1 citations
Correspondence Regarding "Impaired Awareness of Hypoglycemia Continues to be a Risk Factor for Severe Hypoglycemia Despite the Use of Continuous Glucose Monitoring Sys...
David Price, John B. Welsh> ;Endocrine Practice. 2019 Oct 1
38 citations
Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables.
Irl B. Hirsch, J. B. Welsh, P. Calhoun, S. Puhr, David Price> ;Diabetic Medicine. 2019 Jul 17
37 citations
Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert.
Sarah Puhr, Mark Derdzinski, John B. Welsh, Andrew Scott Parker, Tomas C. Walker, David Price> ;Diabetes Technology & Therapeutics. 2019 Mar 30
18 citations
Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes.
John B. Welsh, Xiaohe Zhang, Sarah Puhr, Terri Kang Johnson, Tomas C. Walker, Andrew K. Balo, David Price> ;Journal of Diabetes Science and Technology. 2019 Mar 1
Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth.
Welsh JB, Derdzinski M, Parker AS, Puhr S, Jimenez A, Walker T> ;Diabetes therapy : research, treatment and education of diabetes and related disorders. 2019-01-30
27 citations
Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study...
Liana K. Billings, Christopher G. Parkin, David Price> ;Diabetes Technology & Therapeutics. 2018 Aug 1
The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S, Calhoun P, Welsh JB, Walker TC> ;Diabetes technology & therapeutics. 2018-07-23
37 citations
Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System
Peter Calhoun, Terri Kang Johnson, Jonathan Hughes, David Price, Andrew K. Balo> ;Journal of Diabetes Science and Technology. 2018 Jan 16
285 citations
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
Roy W. Beck, Tonya D Riddlesworth, Katrina J. Ruedy, Andrew J Ahmann, Stacie Haller, Davida F. Kruger, Janet B. McGill, William H. Polonsky, David C. Price, Stephen Ar...> ;Annals of Internal Medicine. 2017 Sep 19
42 citations
Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections
Tonya D Riddlesworth, David Price, Nathan Cohen, Roy W. Beck> ;Diabetes Therapy. 2017 Jun 14
3 citations
Commentary Regarding Shapiro, "Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?"
David Price> ;Journal of Diabetes Science and Technology. 2017 Mar 1
Join now to see all

Journal Articles

Recurrent Diabetic Ketoacidosis Resulting From Spurious Hypoglycemia: A Deleterious Consequence of Inadequate Detection of Partial Strip Filling by a Glucose Monitorin...
Price DA, Clinical Diabetes, 2009